Psikotropik İlaçlar ve Oküler Yan Etkileri

Sönmez, İpek; Aykan, Ümit

doi:10.4274/tjo.67944

Cited by 3 publications

(1 citation statement)

References 74 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The most frequent anticholinergic effects on the eye are mydriasis and cycloplegia, which in turn may cause the blockage of the trabecular meshwork. These effects result in blurred vision due to loss of accommodation and in precipitation of ACG [67][68][69][70] (Figure 1).…”

Section: Tricyclic Antidepressants (Tcas)mentioning

confidence: 99%

Psychopharmacological Treatment, Intraocular Pressure and the Risk of Glaucoma: A Review of Literature

Ciobanu

Dionisie

Neagu

et al. 2021

JCM

View full text Add to dashboard Cite

Through the years, the available psychopharmacological treatments have expanded with numerous new drugs. Besides weight gain, gastro-intestinal problems or Parkinson-like symptoms, ocular adverse effects of psychiatric drugs have been reported. These adverse effects are not common, but can be dangerous for the patient. This review summarises the current knowledge on the risk of raised intraocular pressure and glaucoma entailed by psychopharmacological treatment. Also, it provides updated data for clinicians involved in the treatment of patients with glaucoma or glaucoma risk factors. For this purpose, we performed an extensive literature search in the PubMed database using specific terms. Selective serotonin and noradrenaline reuptake inhibitors are the best evidenced as having no association with glaucoma. Antipsychotics, and especially first generation, seem to have no correlation with an increased intraocular pressure and therefore possibly with a risk of glaucoma, although a special attention should be paid when using ziprasidone. Tricyclic antidepressants, benzodiazepines and topiramate should be avoided in patients diagnosed with glaucoma or at risk. Clinicians should be aware of the possible psychotropic drug induced glaucoma and monitor at risk patients closely in order to prevent this condition. Irrespective of the psychopharmacological regimen taken into consideration, the glaucoma patient should be under the strict supervision of the ophthalmologist.

show abstract

Section: Tricyclic Antidepressants (Tcas)mentioning

confidence: 99%

Psychopharmacological Treatment, Intraocular Pressure and the Risk of Glaucoma: A Review of Literature

Ciobanu

Dionisie

Neagu

et al. 2021

JCM

View full text Add to dashboard Cite

show abstract

Quantitative Analysis of Tear Film in Patients on Atypical Antipsychotics

Dixitha

Abhilash

H.U.

et al. 2023

Ocular Immunology and Inflammation

View full text Add to dashboard Cite

The Interface Between Psychiatry and Ophthalmology

Sadykov

Studnička

Hosák

et al. 2019

Acta Med. (Hradec Kralove, Czech Repub.)

View full text Add to dashboard Cite

Objective: The aim of this article is to review the interface between psychiatry and ophthalmology at several levels, such as the influence of psychopharmacology on eye disorders, the occurrence of psychiatric symptoms in eye diseases, and the neuroophthalmological examination methods supporting the validity of psychiatric diagnoses. Materials and Methods: We searched the PubMed computer database for the key words “Psychiatry” and “Ophthalmology” on the 28th of August, 2018 to obtain relevant articles which were consequently summarized. Results: The results showed that most patients with ocular disease simultaneously have one or more psychiatric symptoms. We also found a prevalence of eye-related side effects in patients who use psychiatric drugs. At the same time, we observed that some ophthalmology methods of diagnostics can be used as diagnostic tools in psychiatry. Conclusions: Most studies showed a significant relation between psychiatry and ophthalmology, such as eye symptoms and diseases following long-term use of psychotropics as well as psychiatric symptoms and syndromes in patients with eye disorders. Our review may be beneficial to psychiatrists, ophthalmologists, and, last but not least, the patients themselves.

show abstract

Psikotropik İlaçlar ve Oküler Yan Etkileri

Cited by 3 publications

References 74 publications

Psychopharmacological Treatment, Intraocular Pressure and the Risk of Glaucoma: A Review of Literature

Psychopharmacological Treatment, Intraocular Pressure and the Risk of Glaucoma: A Review of Literature

Quantitative Analysis of Tear Film in Patients on Atypical Antipsychotics

The Interface Between Psychiatry and Ophthalmology

Contact Info

Product

Resources

About